Link between stress hormone and obesity in depressed and bipolar patients

July 04, 2016

Low levels of the stress hormone cortisol are linked to obesity, high levels of fat in the blood and metabolic syndrome among patients with recurrent depressions or bipolar disorder. This according to a study at Umeå University in Sweden published in the Journal of Affective Disorders.

"These results provide clues to better understand the high prevalence of cardiovascular diseases in people with recurrent depressions or bipolar disorder. The results may in the future contribute to better preventative treatments of cardiovascular diseases in these disorders," says Martin Maripuu, researcher at the Department of Clinical Sciences, Division of Psychiatry at Umeå University.

Bipolar disorder and recurrent depressions are lifelong diseases that are associated with a 10-15 year reduction in life expectancy. A strong contributing factor to the shortened life expectancy is the high prevalence of cardiovascular diseases. Stress, low physical activity and high energy intake are lifestyle factors linked to increased risk of metabolic and cardiovascular diseases.

One of the most important stress system in the body is called the HPA-axis. This system regulates the production and levels of the vital stress hormone cortisol. Cortisol is also important for metabolism.

High cortisol levels over a long period of time is considered to contribute to the accumulation of fat. Stress normally leads to HPA-axis over activity, which in turn leads to increased levels of cortisol. If the additional stress is prolonged, it may lead to underactivity in the stress system, with low levels of cortisol as a result.

In people with recurrent depressions and with bipolar disorder it has previously been shown that metabolic risk factors for cardiovascular diseases are common and that disturbances in the stress regulation system often occur.

In order to study the link between cortisol levels and metabolic diseases, 245 patients with bipolar disorder or recurrent depressions were analysed, together with 258 people in a control group. Researchers measured cortisol levels in participants after they had taken a so-called dexamethasone suppression test, which is used to discover early deviations in the stress system.

What the Umeå researchers now can show is that patients with bipolar disorder or recurrent depressions with low levels of cortisol to a larger extent than other patients suffer from: On the other hand, there was no correlation between cortisol levels and high blood sugar levels or high blood pressure.

"The results show that cortisol regulation is linked to worsened physical health in people with bipolar disorder or recurrent depressions. However, further studies are needed in order to better understand these associations," says Martin Maripuu.
-end-


For more information, please contact:


Martin Maripuu, Department of Clinical Sciences, Division of Psychiatry at Umeå University
Phone: +46 70-617 67 69
Email: martin.maripuu@umu.se
Portrait photo for download
https://mediabank.umu.se/detail/7830

Umea University

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.